Huoxin pill prevents excessive inflammation and cardiac dysfunction following myocardial infarction by inhibiting adverse Wnt/β‑catenin signaling activation-Reference-Cited by-同舟云学术

Huoxin pill prevents excessive inflammation and cardiac dysfunction following myocardial infarction by inhibiting adverse Wnt/β‑catenin signaling activation

Published:2022-09 Issue: Volume:104 Page:154293
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

He Jia,Wo Da,Ma En,Wang Qing,Chen Jinxiao,Gao Qian,Zhao Qiqin,Shen Fang,Peng Jun,Zhu Weidong,Ren Dan-ni

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference38 articles.

1. Influence of kaempferol, a flavonoid compound, on membrane-bound ATPases in streptozotocin-induced diabetic rats;Al-Numair;Pharm. Biol.,2015

2. NF-kappa B: ten years after;Baeuerle;Cell,1996

3. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA;Barandon;Circulation,2003

4. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development;Brault;Development,2001

5. Wnt/beta-catenin signaling and disease;Clevers;Cell,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2024-01-08

2. Axin2 depletion in macrophages alleviated senescence and increased immune response after myocardial infarction;Inflammation Research;2023-12-30

3. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-22

4. Maresin1 ameliorates ventricular remodelling and arrhythmia in mice models of myocardial infarction via NRF2/HO-1 and TLR4/NF-kB signalling;International Immunopharmacology;2022-12